102 STAT. 3078
PUBLIC LAW 100-607—NOV. 4, 1988
cooperation among Federal agencies, State, local, and regional public health agencies, and private entities, in research concerning the diagnosis, prevention, and treatment of acquired immune deficiency s3aidrome. "PART E—GENERAL PROVISIONS
42 USC
300CC-51.
"SEC. 2361. DEFINITION.
"For purposes of this title, the term 'infection with the etiologic agent for acquired immune deficiency syndrome' includes any condition arising from infection with such etiologic agent.". SEC. 202. AUTHORIZATION OF ADDITIONAL PERSONNEL.
(a) IN GENERAL.—Notwithstanding any other provision of law, the Secretary of Health and Human Services, shall, in accordance with the civil service and classification laws, appoint and fix the compensation of not less than 780 employees for the Public Health Service in addition to the number of employees assigned to such Service as of December 31, 1987. (b) REPORT.—Not later than 90 days after the date of the enactment of this Act, the Secretary of Health and Human Services shall report to the Congress on the allocation among the agencies of the Public Health Service of the 780 additional employees required in subsection (a). (c) LIMITATION OF AVAILABILITY OF APPROPRIATIONS.—The require-
ment established in subsection (a) shall be carried out only to the extent of amounts made available in appropriations Acts for such purpose. (d) EXPIRATION OF REQUIREMENT.—Effective October 1, 1990, this section is repealed. 42 USC 300cc note.
SEC. 203. REQUIREMENT OF CERTAIN RESEARCH STUDIES. (a) MORTALITY RATES.—After consultation with the Director of the
National Center for Health Services Research and Health Care Technology Assessment, the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control, shall conduct a study for the purpose of determining the mortality rates with respect to acquired immune deficiency sjmdrome among individuals of various groups at risk of such s5mdrome, among various geographic areas, and among individuals with varying financial resources for the payment of health care services. (b) USE OF CONSORTIA FOR RESEARCH AND DEVELOPMENT.—The
Secretary of Health and Human Services shall request the National Academy of Sciences and other similar appropriate nonprofit institutions to report to the Secretary findings made by such institutions with respect to— (1) the manner in which research on, and the development of, vaccines and drugs for the prevention and treatment of acquired immune deficiency sjnidrome and related conditions can be enhanced by the establishment of consortia— (A) designed to combine and share resources needed for such research and development; and (B) consisting of businesses involved in such research and development, of nonprofit research institutions, or of combinations of such businesses and such institutions; and (2) the appropriate participation, if any, of the Federal Government in such consortia.
�
